论文信息 - A phase II multicenter study of CNTO 328, an anti-IL-6 monoclonal antibody, in patients (pts) with relapsed or refractory multiple myeloma (MM). - 字舞流文

A phase II multicenter study of CNTO 328, an anti-IL-6 monoclonal antibody, in patients (pts) with relapsed or refractory multiple myeloma (MM).

P. Sonneveld | S. Jagannath | P. Voorhees | G. Somlo | P. Wijermans | S. Zweegman | S. Lentzsch | S. Thomas | R. Manges | R. Frank | P. Wijermans | Suzanne Lentzsch | Sundar Jagannath | Richard C. Frank | Sonja Zweegman | Sheeba K. Thomas